The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome

References

1. Anderson R. A., Scobie L., O’Neil B. W., Grindlay G. J., Campo M. S. 1997; Viral proteins of bovine papillomavirus type 4 during the development of alimentary canal tumours. The Veterinary Journal 154:69–78
   [Google Scholar]
2. Avila M. A., Velasco J. A., Cansado J., Notario V. 1994; Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Research 54:2424–2428
   [Google Scholar]
3. Baker S. J., Markowitz S., Fearon E. R., Willson J. K. V., Vogelstein B. 1990; Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915
   [Google Scholar]
4. Barbosa M. S., Lowy D. R., Schiller J. T. 1989; Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. Journal of Virology 63:1404–1407
   [Google Scholar]
5. Cairney M., Campo M. S. 1995; The synergism between bovine papillomavirus type 4 and quercetin is dependent on the timing of exposure. Carcinogenesis 16:1997–2001
   [Google Scholar]
6. Campo M. S., Jarrett W. F. H. 1987; Papillomavirus and disease. In Molecular Basis of Virus Disease, SGM symposium 40 pp. 215–243 Russel W. C., Almond J. W. Edited by Reading, UK: Society for General Microbiology;
   [Google Scholar]
7. Campo M. S., Spandidos D. A. 1983; Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. Journal of General Virology 64:549–557
   [Google Scholar]
8. Campo M. S., Moar M. H., Sartirana M. L., Kennedy I. M., Jarrett W. F. H. 1985; The presence of bovine papillomavirus type 4 DNA is not required for the progression to and the maintenance of the malignant state in cancers of the alimentary canal in cattle. EMBO Journal 4:1819–1825
   [Google Scholar]
9. Campo M. S., McCaffery R. E., Doherty I., Kennedy I. M., Jarrett W. F. H. 1990; The Harvey ras 1 gene is activated in papillomavirus- associated carcinomas of the upper alimentary canal in cattle. Oncogene 5:303–308
   [Google Scholar]
10. Campo M. S., O’Neil B. W., Barron R. J., Jarrett W. F. H. 1994; Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle. Carcinogenesis 15:1597–1601
    [Google Scholar]
11. Chandrachud L. M., O’Neil B. W., Jarrett W. F. H., Grindlay G. J., McGarvie G. M., Campo M. S. 1994; Humoral immune response to the E7 protein of bovine papillomavirus type 4 and identification of B-cell epitopes. Virology 200:98–104
    [Google Scholar]
12. Choo K.-B., Chong K. Y. 1993; Absence of mutation in the p53 and retinoblastoma susceptibility genes in primary cervical carcinomas. Virology 193:1042–1046
    [Google Scholar]
13. Coggins L. W., Scobie L., Jackson M. E., Campo M. S. 1995; Assignment of the bovine p53 gene to chromosome 19q15 by fluorescence in situ hybridization. Mammalian Genome 6:687–688
    [Google Scholar]
14. Crook T., Tidy J. A., Vousden K. H. 1991a; Degradation ofp53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547–556
    [Google Scholar]
15. Crook T., Wrede D., Vousden K. H. 1991b; p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6:873–875
    [Google Scholar]
16. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A., Butel J. S., Bradley A. T. 1992; Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221
    [Google Scholar]
17. Faccini A. M., Cairney M., Ashrafi G. H., Finbow M. E., Campo M. S., Pitts J. D. 1996; The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. Journal of Virology 70:9041–9045
    [Google Scholar]
18. Fujita M., Inoue M., Tanizawa O., Iwamoto S., Enomoto T. 1992; Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Research 52:5323–5328
    [Google Scholar]
19. Gaukroger J., Chandrachud L., Jarrett W. F. H., McGarvie G. E., Yeudall W. A., McCaffery R. E., Smith K. T., Campo M. S. 1991; Malignant transformation of a papilloma induced by bovine papillomavirus type 4 in the nude mouse renal capsule. Journal of General Virology 72:1165–1168
    [Google Scholar]
20. Giri I., Danos O. 1986; Papillomavirus genomes: from sequence data to biological properties. Trends in Genetics 2:227–232
    [Google Scholar]
21. Harvey M., Sands A. T., Weiss R. S., Hegi M. E., Wiseman R. W., Pantazis P., Giovanella B. C., Tainsky M. A., Bradley A., Donehower L. A. 1993; In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8:2457–2467
    [Google Scholar]
22. Jackson M. E., Pennie W. D., McCaffery R. E., Smith K. T., Grindlay G. J., Campo M. S. 1991; The B subgroup bovine papillomaviruses lacks an identifiable E6 open reading frame. Molecular Carcinogenesis 4:382–387
    [Google Scholar]
23. Jaggar R. T., Pennie W. D., Smith K. T., Jackson M. E., Campo M. S. 1990; Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. Journal of General Virology 71:3041–3046
    [Google Scholar]
24. Munger K., Werness B. A., Dyson N., Phelps W. C., Harlow E., Howley P. M. 1989; Compl ex formation of human papillomavirus E7 proteins with the retinoblastoma tumour suppressor gene product. EMBO Journal 8:4099–4105
    [Google Scholar]
25. Munger K., Scheffner M., Huibregtse J. M., Howley P. M. 1992; Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surveys 12:197–217
    [Google Scholar]
26. Pennie W. D., Campo M. S. 1992; Synergism between bovine papillomavirus type 4 and the flavonoid quercetin in cell transformation in vitro. Virology 190:861–865
    [Google Scholar]
27. Pennie W. D., Grindlay G. J., Cairney M., Campo M. S. 1993; Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193:614–620
    [Google Scholar]
28. Plaumann B., Fritsche M., Rimpler H., Brandner G., Hess R. D. 1996; Flavonoids activate wild-type 53. Oncogene 13:1605–1614
    [Google Scholar]
29. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. 1990; The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
    [Google Scholar]
30. Scobie L. 1996 The role of p53 in cell transformation by BPV-4 PhD thesis University of Glasgow, UK:
    [Google Scholar]
31. Sedman S. A., Hubbert N. L., Vass W. C., Lowy D. R., Schiller J. T. 1992; Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalisation of human keratinocytes but does not have E6 associated transactivation or transforming activity. Journal of Virology 66:4201–4208
    [Google Scholar]
32. Smith K. T., Campo M. S. 1988; ‘Hit and run’ transformation of mouse C127 cells by bovine papillomavirus type 4: the viral DNA is required for the initiation but not for maintenance of the transformed phenotype. Virology 164:39–47
    [Google Scholar]
33. Storey A., Pim D., Murray A., Osborn K., Banks L., Crawford L. 1988; Comparison of the in vitro transforming activities of human papillomavirus types. EMBO Journal 7:1815–1820
    [Google Scholar]
34. Zatsepina O., Braspenning J., Robberson D., Hajibagheri M. A. N., Blight K. J., Ely S., Hibma M., Spitkovsky D., Trendelenburg M., Crawford L., Tommasino M. 1997; The human papillomavirus type 16 E7 protein is associated with the nucleolus in mammalian and yeast cells. Oncogene 14:1137–1145
    [Google Scholar]